biospectrumasiaSeptember 04, 2017
Tag: Lakewood-Amedex , Geoffrey F. Cox
Lakewood-Amedex (developer of novel anti-infective pharmaceuticals) announced that Neil J. Campbell, MA, MBA, and Leonard DeRoma, MBA, will be joining the company's Board of Directors. Mr. Campbell has over 25 years as a global C-level serial entrepreneur executive, academic professor, and investment partner. He has experience from concept through commercialization of over 300 products and services to-date. Mr. DeRoma has 40 years of experience in senior financial institution positions, and is founder of Invictus Group LLC, a bank advisory firm, and Chief Executive Officer of Wildwood Capital LLC, a small boutique advisory firm focused on strategic advice, mergers and acquisitions, and fund raising for small and middle market companies. They will be joining Lakewood-Amedex's current board members: Steve Parkinson, Executive Director and Chairman, and Geoffrey F. Cox, PhD.
Steve Parkinson, Lakewood-Amedex's CEO and President, said, "We are thrilled to have Neil and Lenny join our Board of Directors. Their depth of experience and leadership expertise in both the commercial operations and financing of development-stage biopharmaceutical companies will lend an essential perspective to our board. With the upcoming completion of our Phase 1/2a clinical trial using our topical Bisphosphocin Nu-3 for infected diabetic foot ulcers (DFU), their independent strategic insight will be crucial to successfully guiding our Bisphosphocin pipeline through to potential FDA approval."
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: